In this episode, Bea continues her conversation with Prof. Dr Peter Seeberger, a managing director at the Max Planck Institute for Colloids and Interfaces, about carbohydrate-based vaccines.


They talk about the current vaccine market and its future potential, the traditional field of vaccinology, and the obstacles one faces when trying to introduce change to an established product market.


Peter talks about developing antibodies and using them in creating cancer vaccines, and the different tasks involved in designing the vaccines for treatment and prevention, i.e. for cancer patients versus for the general population.


Peter talks more about the companies that have been founded by his lab, about the successes, the failures, the lessons learned along the way, and the opportunities that such start-ups offer to make new tools available for a larger population and to expand a research field.


Peter and Bea also discuss how recent years have shown the fundamental importance of chemistry in all areas of our lives.


Learn more about Prof. Dr. Seeberger's lab and research here: https://www.mpikg.mpg.de/en/bs and https://www.peter-seeberger.de


Cover Photo: © Sebastian Rost / Max-Planck-Institut für Kolloid- und Grenzflächenforschung


Episode Art: Photo by Photo by Louis Reed(@_louisreed) on Unsplash (https://unsplash.com/)


You can follow us on:


Twitter: https://twitter.com/MPPhdnetPodcast


Instagram: https://www.instagram.com/offspringmagazine_thepodcast


Linkedin: https://www.linkedin.com/company/offspring-magazine-the-podcast


YouTube: https://youtube.com/c/MaxPlanckPhDnet


If you have any feedback, comments, or suggestions, reach out to us at [email protected]


Check out the Offspring-Blog where we publish articles on a regular basis: https://www.phdnet.mpg.de/outreach/offspring-blog


Intro - Outro music composed by Srinath Ramkumar: https://twitter.com/srinathramkumar


Pre-Intro jingle composed by Gustavo Carrizo: https://www.instagram.com/carrizo.gus


See you soon!

Twitter Mentions